Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Annovis Bio, Inc. (ANVS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Annovis Bio, Inc. (ANVS), most recent 12 months reported: net loss $49.52M. Latest balance sheet on file: liquid cash $18.73M. From SEC filings. Others in Pharmaceutical Preparations: ANIXA BIOSCIENCES, INC. · ANNEXON, INC. · Alto Neuroscience, Inc. · AN2 Therapeutics, Inc. · Aprea Therapeutics, Inc. · APIMEDS PHARMACEUTICALS US, INC. · Aptevo Therapeutics Inc. · ARTELO BIOSCIENCES, INC.

Stock screener

Watchlist